Moo-Yeal Lee

Prof. Moo-Yeal Lee


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2014 in Nature Communications
Verified
Journal Article
Open access
PDF file
SKSeok Joon Kwon
Seok Joon Kwon
DLDong Woo Lee
Dong Woo Lee
DSDhiral A. Shah
Dhiral A. Shah
BKBosung Ku
Bosung Ku
SJSang Youl Jeon
Sang Youl Jeon
MLMoo-Yeal Lee
Moo-Yeal Lee
Differential expression of various drug-metabolizing enzymes (DMEs) in the human liver may cause deviations of pharmacokinetic profiles, resulting in interindividual variability of drug toxicity and/or efficacy. Here, we present the ‘Transfected Enzyme and Metabolism Chip’ (TeamChip), which predicts potential metabolism-induced drug or drug-candidate toxicity. The TeamChip is prepared by delivering genes into miniaturized three-dimensional cellular microarrays on a micropillar chip using recombinant adenoviruses in a complementary microwell chip. The device enables users to manipulate the expression of individual and multiple human metabolizing-enzyme genes (such as CYP3A4, CYP2D6, CYP2C9, CYP1A2, CYP2E1 and UGT1A4) in THLE-2 cell microarrays. To identify specific enzymes involved in drug detoxification, we created 84 combinations of metabolic-gene expressions in a combinatorial fashion on a single microarray. Thus, the TeamChip platform can provide critical information necessary for evaluating metabolism-induced toxicity in a high-throughput manner.

14 December 2015 in Biosensors
Verified
Journal Article
Open access
PDF file
PJPranav Joshi
Pranav Joshi
MLMoo-Yeal Lee
Moo-Yeal Lee
High content imaging (HCI) is a multiplexed cell staining assay developed for better understanding of complex biological functions and mechanisms of drug action, and it has become an important tool for toxicity and efficacy screening of drug candidates. Conventional HCI assays have been carried out on two-dimensional (2D) cell monolayer cultures, which in turn limit predictability of drug toxicity/efficacy in vivo; thus, there has been an urgent need to perform HCI assays on three-dimensional (3D) cell cultures. Although 3D cell cultures better mimic in vivo microenvironments of human tissues and provide an in-depth understanding of the morphological and functional features of tissues, they are also limited by having relatively low throughput and thus are not amenable to high-throughput screening (HTS). One attempt of making 3D cell culture amenable for HTS is to utilize miniaturized cell culture platforms. This review aims to highlight miniaturized 3D cell culture platforms compatible with current HCI technology.

1 January 2017 in BioMed Research International
Verified
Journal Article
Open access
PDF file
ARAlexander D. Roth
Alexander D. Roth
MLMoo-Yeal Lee
Moo-Yeal Lee
Idiosyncratic drug-induced liver injury (IDILI) is a significant source of drug recall and acute liver failure (ALF) in the United States. While current drug development processes emphasize general toxicity and drug metabolizing enzyme- (DME-) mediated toxicity, it has been challenging to develop comprehensive models for assessing complete idiosyncratic potential. In this review, we describe the enzymes and proteins that contain polymorphisms believed to contribute to IDILI, including ones that affect phase I and phase II metabolism, antioxidant enzymes, drug transporters, inflammation, and human leukocyte antigen (HLA). We then describe the various assays that have been developed to detect individual reactions focusing on each of the mechanisms described in the background. Finally, we examine current trends in developing comprehensive models for examining these mechanisms. There is an urgent need to develop a panel of multiparametric assays for diagnosing individual toxicity potential.

19 May 2016 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
JKJihoon Kang
Jihoon Kang
DLDong Woo Lee
Dong Woo Lee
HHHyun Ju Hwang
Hyun Ju Hwang
SYSang-Eun Yeon
Sang-Eun Yeon
MLMoo-Yeal Lee
Moo-Yeal Lee
HKHyo-Jeong Kuh
Hyo-Jeong Kuh
Three-dimensional (3D) cancer cell culture models mimic the complex 3D organization and microenvironment of human solid tumor tissue and are thus considered as highly predictive models representing avascular tumor regions.

10 September 2023 in Advanced Healthcare Materials
Verified
Journal Article
Open access
SKSoo‐Yeon Kang
Soo‐Yeon Kang
MKMasaki Kimura
Masaki Kimura
SSSunil Shrestha
Sunil Shrestha
PLPhillip Lewis
Phillip Lewis
SLSangjoon Lee
Sangjoon Lee
MLMoo-Yeal Lee
Moo-Yeal Lee
Human organoids have the potential to revolutionize in vitro disease modeling by providing multicellular architecture and function that are similar to those in vivo. This innovative and evolving technology, however, still suffers from assay throughput and reproducibility to enable high‐throughput screening (HTS) of compounds due to cumbersome organoid differentiation processes and difficulty in scale‐up and quality control. Using organoids for HTS is further challenged by the lack of easy‐to‐use fluidic systems that are compatible with relatively large organoids. Here, these challenges are overcome by engineering “microarray three‐dimensional (3D) bioprinting” technology and associated pillar and perfusion plates for human organoid culture and analysis. High‐precision, high‐throughput stem cell printing, and encapsulation techniques are demonstrated on a pillar plate, which is coupled with a complementary deep well plate and a perfusion well plate for static and dynamic organoid culture. Bioprinted cells and spheroids in hydrogels are differentiated into liver and intestine organoids for in situ functional assays. The pillar/perfusion plates are compatible with standard 384‐well plates and HTS equipment, and thus may be easily adopted in current drug discovery efforts.

20 April 2024 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
SSSunil Shrestha
Sunil Shrestha
VLVinod Kumar Reddy Lekkala
Vinod Kumar Reddy Lekkala
PAPrabha Acharya
Prabha Acharya
SKSoo-Yeon Kang
Soo-Yeon Kang
MVManav Goud Vanga
Manav Goud Vanga
MLMoo-Yeal Lee
Moo-Yeal Lee
We developed microarray 3D bioprinting technology and associated pillar/deep well plates that allow high-throughput, miniature, and uniform culture of human liver organoids (HLOs) from bioprinted foregut cells and facilitate in situ assessments.